Nov 30, 2017
1:20
For every 20 shares held, investors received 1. The price per share adjusted from $0.15 to $3.10.
The split itself did not change the total investment value.
Neuren Pharmaceuticals Limited (ASX:NEU) operates in the Pharmaceuticals: generic industry.
Neuren Pharmaceuticals Limited company overviewNeuren Pharmaceuticals Limited's most recent stock split was on November 30, 2017. It was a 1-for-20 reverse split, so shareholders received 1 share for every 20 they held.
Neuren Pharmaceuticals Limited (ASX:NEU) has split its stock 3 times: a 27-for-25 split on December 24, 2007, a 32-for-29 split on June 21, 2011, and a 1-for-20 reverse split on November 30, 2017.
Neuren Pharmaceuticals Limited has split its stock 3 times. This history records 3 splits between December 24, 2007 and November 30, 2017.
A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In Neuren Pharmaceuticals Limited's 1-for-20 reverse split on November 30, 2017, every 20 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.
Neuren Pharmaceuticals Limited has not announced a new split in our records. Its most recent split was on November 30, 2017, 8 years ago. Companies announce splits in advance, and any new ASX:NEU split will appear on this page.
Already premium?